Ribonuclease zymogen induces cytotoxicity upon HIV-1 infection.
Ian W WindsorDawn M DudleyDavid H O'ConnorRonald T RainesPublished in: AIDS research and therapy (2021)
These data demonstrate the utility of ribonuclease zymogens as biologic prodrugs.